VANGUARD GROUP INC - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 39 filers reported holding THE ONCOLOGY INSTITUTE INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$2,461,248
+153.7%
1,758,034
-0.3%
0.00%
Q2 2023$969,975
-26.4%
1,762,950
-9.3%
0.00%
Q1 2023$1,317,528
-58.7%
1,943,543
+0.6%
0.00%
Q4 2022$3,188,799
-63.0%
1,932,606
+3.9%
0.00%
Q3 2022$8,613,000
+8.0%
1,860,242
+18.1%
0.00%
Q2 2022$7,972,000
+33.4%
1,575,435
+87.9%
0.00%
Q1 2022$5,977,000
+38.6%
838,321
+89.5%
0.00%
Q4 2021$4,313,000442,3440.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q2 2023
NameSharesValueWeighting ↓
Triatomic Management LP 517,479$853,8400.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 104,400$1720.25%
Prosight Management, LP 275,561$454,6760.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,360,052$5,544,0860.12%
Redmile Group, LLC 1,583,158$2,612,2110.11%
Alpine Global Management, LLC 46,326$760.02%
Saba Capital Management, L.P. 174,513$287,9460.00%
FMR LLC 12,001,982$19,803,2700.00%
Leucadia National 192,452$317,5460.00%
BANK OF AMERICA CORP /DE/ 31,995$52,7920.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders